Ex­clu­sive: TCG, DCVC and Lux back new au­toim­mune biotech from Kally­ope co-founder

A stealth biotech from re­peat col­lab­o­ra­tors has as­sem­bled the lat­est in­dus­try megaround.

New York-based NI­LO Ther­a­peu­tics has put to­geth­er a $101 mil­lion Se­ries A, Tim …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER